FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Enzo Boeri

Research Profile

Living Beings

Disorders

HIV Infections

Physiology

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

Italy

Genes & Molecular Sequences

Genes, env

Co-author Network

Publications

TOP 3
Elena Seminari; Carmine Tinelli; Genny Meini; Grazia Punzi; Enzo Boeri; Bianca Bruzzone; Annapaola Callegaro; Annalisa De Silvestri; Nicola Gianotti; Paolo Grossi
Response to antiretroviral treatment after failure of NNRTI plus NRTIs-based therapy. Data from the ARCA collaborative group.
Filippo Canducci; Antonella Castagna; E Ceresola; F Cossarin; Andrea Galli; Nicola Gianotti; Adriano Lazzarin; Silvia Nozza; Michela Sampaolo; V Spagnuolo; B Barda; Enzo Boeri; Massimo Clementi
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.
Francesca Cossarini; Enzo Boeri; Filippo Canducci; Stefania Salpietro; Alba Bigoloni; Laura Galli; Vincenzo Spagnuolo; Antonella Castagna; Massimo Clementi; Adriano Lazzarin; Nicola Gianotti
Integrase and fusion inhibitors transmitted drug resistance in naive patients with recent diagnosis of HIV-1 infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Enzo Boeri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Elena Seminari; Carmine Tinelli; Genny Meini; Grazia Punzi; Enzo Boeri; Bianca Bruzzone; Annapaola Callegaro; Annalisa De Silvestri; Nicola Gianotti; Paolo Grossi
Response to antiretroviral treatment after failure of NNRTI plus NRTIs-based therapy. Data from the ARCA collaborative group.
Current HIV research 2012;10(4):334-40.
2011: Filippo Canducci; Antonella Castagna; E Ceresola; F Cossarin; Andrea Galli; Nicola Gianotti; Adriano Lazzarin; Silvia Nozza; Michela Sampaolo; V Spagnuolo; B Barda; Enzo Boeri; Massimo Clementi
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2011;17(6):928-34.
2011: Francesca Cossarini; Enzo Boeri; Filippo Canducci; Stefania Salpietro; Alba Bigoloni; Laura Galli; Vincenzo Spagnuolo; Antonella Castagna; Massimo Clementi; Adriano Lazzarin; Nicola Gianotti
Integrase and fusion inhibitors transmitted drug resistance in naive patients with recent diagnosis of HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2011;56(2):e51-4.
2010: Filippo Canducci; Maria Chiara Marinozzi; Michela Sampaolo; Enzo Boeri; Vincenzo Spagnuolo; Nicola Gianotti; Antonella Castagna; Stefania Paolucci; Fausto Baldanti; Adriano Lazzarin; Massimo Clementi
Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.
The Journal of antimicrobial chemotherapy 2010;65(3):425-33.
2009: Maurizio Zazzi; Mattia Prosperi; ilaria vicenti; Simona Di Giambenedetto; Annapaola Callegaro; Bianca Bruzzone; Fausto Baldanti; Angela Gonnelli; Enzo Boeri; Elisabetta Paolini; Stefano Rusconi; Andrea Giacometti; Franco Maggiolo; Stefano Menzo; Andrea De Luca
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.
The Journal of antimicrobial chemotherapy 2009;64(3):616-24.
2009: Filippo Canducci; Michela Sampaolo; Maria Chiara Marinozzi; Enzo Boeri; Vincenzo Spagnuolo; Andrea Galli; Antonella Castagna; Adriano Lazzarin; Massimo Clementi; Nicola Gianotti
Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies.
AIDS (London, England) 2009;23(4):455-60.
2009: Simona Di Giambenedetto; Maurizio Zazzi; Paola Corsi; Angela Gonnelli; Massimo Di Pietro; Andrea Giacometti; Paolo Almi; Michele Trezzi; Enzo Boeri; Nicola Gianotti; Stefano Menzo; Romana Del Gobbo; Daniela Francisci; Alessandro Nerli; Luisa Galli; Andrea De Luca
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
Antiviral therapy 2009;14(3):359-69.
2008: Nicola Gianotti; Simon Tiberi; Stefano Menzo; Anna Danise; Enzo Boeri; Laura Galli; Massimo Clementi; Adriano Lazzarin; Antonella Castagna
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy.
Journal of medical virology 2008;80(2):201-8.
2007: Stefano Rusconi; Nicola Gianotti; Fulvio Adorni; Enzo Boeri; Stefano Menzo; Angela Gonnelli; Valeria Micheli; Paola Meraviglia; Michele Trezzi; Elisabetta Paolini; Andrea Giacometti; Paola Corsi; Massimo Di Pietro; Laura Monno; Grazia Punzi; Maurizio Zazzi
Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis).
Journal of acquired immune deficiency syndromes (1999) 2007;46(3):373-5.
2007: Hamid Hasson; Barbara Mantelli; Priscilla Biswas; Mauro S Malnati; Nicola Gianotti; Annunciata Vecchi; Silvia Nozza; Massimo Cernuschi; Enzo Boeri; Mario Clerici; Adriano Lazzarin; Alberto Beretta
Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1.
Journal of medical virology 2007;79(11):1640-9.
2006: Nicola Gianotti; Laura Galli; Anna Danise; Hamid Hasson; Enzo Boeri; Adriano Lazzarin; Antonella Castagna
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir.
Journal of medical virology 2006;78(12):1537-41.
2006: Nicola Gianotti; Vincenzo Mondino; Maria Cristina Rossi; Elisabetta Chiesa; Ivano Mezzaroma; Nicoletta Ladisa; Giovanni Guaraldi; Carlo Torti; Pierluigi Tarquini; Paula Castelli; Aldo Di Carlo; Enzo Boeri; Wilco Keulen; Paula Mc Kenna; Adriano Lazzarin
Comparison of a rule-based algorithm with a phenotype-based algorithm for the interpretation of HIV genotypes in guiding salvage regimens in HIV-infected patients by a randomized clinical trial: the mutations and salvage study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(10):1470-80.
2006: Antonella Castagna; Anna Danise; Stefano Menzo; Laura Galli; Nicola Gianotti; Elisabetta Carini; Enzo Boeri; Andrea Galli; Massimo Cernuschi; Hamid Hasson; Massimo Clementi; Adriano Lazzarin
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).
AIDS (London, England) 2006;20(6):795-803.
2006: Nicola Gianotti; Laura Galli; Enzo Boeri; Anna de Bona; Monica Guffanti; Anna Danise; Stefania Salpietro; Adriano Lazzarin; Antonella Castagna
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2006;41(4):447-52.
2005: Nicola Gianotti; Laura Galli; Enzo Boeri; Myriam Maillard; Giuseppe Serra; Deborah Ratti; Giulia Gallotta; Daniela Vacchini; Ylenia Tremolada; Adriano Lazzarin; Massimo Clementi; Antonella Castagna
In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients.
The new microbiologica 2005;28(4):319-26.
2005: Nicola Gianotti; Elena Seminari; Adriano Lazzarin; Enzo Boeri; Massimo Clementi; Anna Danise; Stefania Salpietro; Giuliana Fusetti; Antonella Castagna
Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen.
AIDS research and human retroviruses 2005;21(6):545-54.
2005: Nicola Gianotti; Elena Seminari; Monica Guffanti; Enzo Boeri; Paola Villani; Mario Regazzi; Alba Bigoloni; Giulia Schira; Simon Tiberi; Giuliana Fusetti; Adriano Lazzarin; Antonella Castagna
Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir.
The new microbiologica 2005;28(2):119-25.
2004: Nicola Gianotti; Elena Seminari; Giuliana Fusetti; Stefania Salpietro; Enzo Boeri; Andrea Galli; Adriano Lazzarin; Massimo Clementi; Antonella Castagna
Impact of a treatment including tenofovir plus didanosine on the selection of the 65R mutation in highly drug-experienced HIV-infected patients.
AIDS (London, England) 2004;18(16):2205-8.
2004: Antonella Castagna; Nicola Gianotti; Laura Galli; Anna Danise; Hamid Hasson; Enzo Boeri; Richard Hoetelmans; David Nauwelaers; Adriano Lazzarin
The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimen.
Antiviral therapy 2004;9(4):537-43.
2004: Nicola Gianotti; Enzo Boeri; M Maillard; G Serra; D Ratti; Giulia Gallotta; Daniela Vacchini; Y Tremolada; Antonella Castagna
In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results.
The new microbiologica 2004;27(2 Suppl 1):111-7.
2004: Enzo Boeri; Filippo Canducci; Maria Antonietta Grasso; Silvia Presi; Paola Carrera; Sara Racca; Massimo Clementi
Phylogenetic internal control for HIV-1 genotypic antiretroviral testing.
The new microbiologica 2004;27(2 Suppl 1):105-9.
2004: Nicola Gianotti; Alessandro Soria; Laura Galli; Barbara Giudici; Giuliana Fusetti; Adriano Lazzarin; Enzo Boeri; Antonella Castagna
Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcome.
AIDS (London, England) 2004;18(5):821-3.
2004: Hamid Hasson; Nicola Gianotti; Anna Danise; Elena Seminari; Enzo Boeri; Silvia Nozza; Antonella Castagna; Adriano Lazzarin
Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients.
AIDS (London, England) 2004;18(1):123-7.
2003: Enzo Boeri; Nicola Gianotti; Filippo Canducci; Hamid Hasson; Barbara Giudici; Antonella Castagna; Adriano Lazzarin; Massimo Clementi
Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressure.
AIDS research and human retroviruses 2003;19(12):1151-3.
2003: Caterina Uberti-Foppa; Anna de Bona; Giulia Morsica; Laura Galli; Giulia Gallotta; Enzo Boeri; Adriano Lazzarin
Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;33(2):146-52.
2003: Filippo Canducci; Caterina Uberti-Foppa; Enzo Boeri; Sara Racca; Giulia Gallotta; Maria Antonietta Grasso; Giliola Calori; Adriano Lazzarin; Massimo Clementi
Characterization of GBV-C infection in HIV-1 infected patients.
Journal of biological regulators and homeostatic agents 2003;17(2):191-4.
2001: Anna M Brambilla; Antonella Castagna; B Nocita; Hamid Hasson; Enzo Boeri; F Veglia; Adriano Lazzarin
Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections.
Journal of acquired immune deficiency syndromes (1999) 2001;27(1):44-8.
2001: Nicola Gianotti; Giuseppe Tambussi; Enzo Boeri; Adriano Lazzarin
Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor.
Journal of biological regulators and homeostatic agents 2001;15(2):166-9.
2001: Paola Cinque; Silvia Presi; Arabella Bestetti; Chiara Pierotti; Sara Racca; Enzo Boeri; P Morelli; Paola Carrera; M Ferrari; Adriano Lazzarin
Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid.
AIDS research and human retroviruses 2001;17(5):377-83.
2000: Nicola Gianotti; Caterina Uberti-Foppa; Enzo Boeri; M Marinelli; G Tambussi; Renato Finazzi; A Lazzarin
Hepatitis B surface antigen clearance and appearance of antibodies against hepatitis B surface antigen after treatment with recombinant interleukin 2 in a human immunodeficiency virus-infected patient.
Hepatology (Baltimore, Md.) 2000;32(6):1409-10.
2000: Lucia Lopalco; Claudia Pastori; Antonio Cosma; Samuele E Burastero; Brunella Capiluppi; Enzo Boeri; Alberto Beretta; Adriano Lazzarin; Antonio G Siccardi
Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.
AIDS research and human retroviruses 2000;16(2):109-15.
1999: Caterina Uberti-Foppa; Anna de Bona; Giulia Morsica; Monica Guffanti; Nicola Gianotti; Enzo Boeri; Adriano Lazzarin
Recombinant interleukin-2 for treatment of HIV reduces hepatitis C viral load in coinfected patients.
AIDS (London, England) 1999;13(1):140-1.
1998: Giuseppe Tambussi; Enzo Boeri; Paola Carrera; Nicola Gianotti; Adriano Lazzarin
Prevalence of mutation associated to resistance with nucleoside analogues in a cohort of naïve HIV-1 positive subjects during the period 1984-1997.
Journal of biological regulators and homeostatic agents 1998;12(1-2 Suppl):32-4.
1997: Lucia Lopalco; Claudia Pastori; Claudia Barassi; Lucinda Furci; Samuele E Burastero; Flavia B Lillo; Enzo Boeri; Laura Soldini; Giuseppe Tambussi; Adriano Lazzarin; Alberto Beretta; Antonio G Siccardi
Heterogeneity in exposed uninfected individuals.
Journal of biological regulators and homeostatic agents 1997;11(1-2):27-31.
1996: P Bettini; Enzo Boeri; Flavia B Lillo; C Abecasis; E Farma; E Crociati; Caterina Uberti-Foppa; Oliviero Varnier
HIV-1 RNA quantification by one-tube quantitative NASBA in HIV-infected patients.
AIDS (London, England) 1996;10(14):1735-7.
1996: E Farma; Enzo Boeri; P Bettini; C M Repetto; J McDermott; Flavia B Lillo; Oliviero Varnier
Single-step PCR in molecular diagnosis of hepatitis C virus infection.
Journal of clinical microbiology 1996;34(12):3171-4.
1995: E Farma; Enzo Boeri; Giulia Morsica; J McDermott; Laura Soldini; C M Repetto; B Ferioli; G Pellizzari; F Molinari; A Molinelli
"Single step" PCR with a sensitivity similar to nested PCR for the detection of hepatitis C virus RNA.
Clinical and experimental rheumatology 1995;13 Suppl 13():S59-61.
1995: Enzo Boeri; C Abecasis; Oliviero Varnier; G Franchini
Analysis of HTLV-I Env gene sequence from an Italian polytransfused patient: evidence for a Zairian HTLV-I in Sicily.
AIDS research and human retroviruses 1995;11(5):649-51.
1994: Pier Giorgio Mori; Mirella Pasino; C Dufour; Enzo Boeri; A C Molinari
Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and rhG-CSF in the treatment of a child with severe chronic neutropenia.
Blood 1994;84(9):3244-5.
1994: I J Koralnik; Enzo Boeri; W C Saxinger; A L Monico; J Fullen; Antoine Gessain; Hong-Guang Guo; Robert C Gallo; Phillip Markham; V Kalyanaraman
Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission.
Journal of virology 1994;68(4):2693-707.
1994: Antoine Gessain; I J Koralnik; J Fullen; Enzo Boeri; C Mora; A Blank; E F Salazar-Grueso; J Kaplan; W C Saxinger; M Davidson
Phylogenetic study of ten new HTLV-I strains from the Americas.
AIDS research and human retroviruses 1994;10(1):103-6.
1993: Antoine Gessain; Enzo Boeri; R Yanagihara; Robert C Gallo; Genoveffa Franchini
Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions.
Journal of virology 1993;67(2):1015-23.
1993: Enzo Boeri; Antoine Gessain; B Garin; K Kazadi; Guy de Thé; Genoveffa Franchini
Qualitative changes in the human T-cell leukemia/lymphotropic virus type I env gene sequence in the spastic versus nonspastic tropical paraparesis are not correlated with disease specificity.
AIDS research and human retroviruses 1993;9(1):1-5.
1992: Paolo Perutelli; P Biglino; A C Molinari; Enzo Boeri; Pier Giorgio Mori
[Platelet hyperaggregation induced by an antiplatelet monoclonal antibody in a female patient with essential thrombocythemia of childhood].
Recenti progressi in medicina 1992;83(12):688-9.
1992: Enzo Boeri; A Giri; Flavia B Lillo; G Ferrari; Oliviero Varnier; A Ferro; S Sabbatani; W C Saxinger; Genoveffa Franchini
In vivo genetic variability of the human immunodeficiency virus type 2 V3 region.
Journal of virology 1992;66(7):4546-50.
1992: Antoine Gessain; Enzo Boeri; K Kazadi; B Garin; J J Salaün; Robert C Gallo; Guy de Thé; Genoveffa Franchini
[HTLV-I retroviral variant in Zaire in patient with chronic neuromyelopathy. Nucleotidic sequence of the envelope gene].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1992;314(4):159-64.
1989: F Favareto; Daniela Caprino; C Micalizzi; Cristina Rosanda; Enzo Boeri; Pier Giorgio Mori
New clinical aspects of Pearson's syndrome. Report of three cases.
Haematologica 1989;74(6):591-4.
1988: Giovanni Serra; Wanda Bonacci; F Lazzini; P Mezzano; A C Molinari; Enzo Boeri; P Magliano; G B Ravera
[Normotest in the early neonatal period].
La Pediatria medica e chirurgica : Medical and surgical pediatrics 1988;10(4):365-8.
1987: M Pecorara; L Casarino; Pier Giorgio Mori; Massimo Morfini; G Mancuso; A M Scrivano; Enzo Boeri; A C Molinari; R De Biasi; N Ciavarella
Hemophilia A: carrier detection and prenatal diagnosis by DNA analysis.
Blood 1987;70(2):531-5.
1987: Pier Giorgio Mori; Enzo Boeri; A C Molinari; S Odino; F Favareto; M Pecorara; R Arigliani
[Diagnostic usefulness and predictive value of laboratory tests in disseminated vascular coagulation].
La Pediatria medica e chirurgica : Medical and surgical pediatrics 1987;9(4):469-72.
1987: R Arigliani; A C Molinari; F Favareto; T Traverso; C Melevendi; Enzo Boeri; Pier Giorgio Mori
[Splenectomy and infection in homozygous beta-thalassemia. The uselessness of penicillin prophylaxis].
La Pediatria medica e chirurgica : Medical and surgical pediatrics 1987;9(3):281-2.
1987: Oliviero Varnier; G Pellizzari; Flavia B Lillo; C M Repetto; Enzo Boeri; Giovanni Melioli; G C Schito
Recombinant DNA-coded antigens: second-generation tests for the diagnosis of HTLV-III infection.
Antibiotics and chemotherapy 1987;38():180-5.
1986: Pier Giorgio Mori; F Favareto; A Schenone; A C Molinari; Enzo Boeri; L Massimo; R Bandelloni; G Sansone
Congenital dyserythropoietic anemia type I: report of a pair of siblings.
Acta haematologica 1986;75(4):219-23.
1985: Oliviero Varnier; Giovanni Melioli; A Merli; G C Schito; G Tudor; Enzo Boeri; A C Molinari; Pier Giorgio Mori
Evidence for a 1980 HTLV-III infection in a currently asymptomatic B hemophiliac in Italy.
JAMA : the journal of the American Medical Association 1985;254(11):1449-50.
1985: Enzo Boeri; T Lanza; A C Molinari; A Barabino; M Pecorara; Paolo Perutelli; F Favareto; R Arigliani; Pier Giorgio Mori
[Idiopathic chronic thrombocytopenia of childhood treated with immunoglobulins].
Minerva pediatrica 1985;37(17):637-8.
1985: A C Molinari; P G Mori; Enzo Boeri; A Barabino; Mirella Pasino; C F Bertorello; M P Lanteri
Hepatitis B virus infection in patients with antibody to hepatitis B surface antigen.
Transfusion 1985;25(3):289-90.
1982: Wanda Bonacci; Enzo Boeri; G P Tonini; T Lanza; P L Bruschettini; Pier Giorgio Mori; G Serra
[Antithrombin III in the 1st days of life].
Minerva pediatrica 1982;34(20):837-40.
1982: Hamisa J Hassan; M Orlando; G P Tonini; P Casalbore; A Sarti; Enzo Boeri; R Giacchino; L Tentori; P G Mori
An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation.
Scandinavian journal of haematology 1982;29(4):287-94.
1982: Pier Giorgio Mori; Cristina Rosanda; G P Tonini; Enzo Boeri; Mirella Pasino; M C Bisogni; S Rovida
[Detection of carriers of hemophilia A using 3 methods of statistical analysis].
Haematologica 1982;67(4):539-55.